Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor,…
Avistone Announces Encouraging Results for Vebreltinib plus Andamertinib (PLB1004) in EGFR-mutated NSCLC with MET Amplification or Overexpression at ASCO Annual Meeting 2025
BEIJING--(BUSINESS WIRE)--Beijing Avistone Biotechnology Co., Ltd (“Avistone”), an innovative biotechnology company focused…
AllDomains Launches .sol Plus: Upgrade Solution That Brings Revenue-Sharing to .sol Domain Owners
New York City, NY, United States, May 23, 2025 (GLOBE NEWSWIRE) --…
Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
May 23, 2025 16:15 ET | Source: Plus Therapeutics Inc. HOUSTON, May…
Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting
Preliminary efficacy analysis from the elacestrant plus everolimus and ribociclib cohorts of the…
Ragnarok Idle Adventure Plus Official Launching in Taiwan, Hong Kong and Macau on May 21, 2025
Seoul, South Korea, May 21, 2025 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd.…
Hettich India Launches Seamless Silent Sliding with the All-New SlideLine 16 Plus
MUMBAI, India, May 13, 2025 /PRNewswire/ -- Hettich, the renowned German lifestyle brand,…
Nexteer Hosts Global Supplier Conference, Strengthens Agility, Resilience & Sustainability
SUZHOU, China, April 29, 2025 /PRNewswire/ -- Nexteer Automotive hosted an estimated…
GenF20 Plus Under Review: Why Choose GenF20 Plus Over The Other Popular HGH Releaser Supplement?
Limassol, Cyprus, April 20, 2025 (GLOBE NEWSWIRE) -- GenF20 Plus is an…
VigRX Plus Reviews Uncovered: Shocking 2025 Report Reveals the Truth
Limassol, Cyprus, April 19, 2025 (GLOBE NEWSWIRE) -- Male enhancement supplements have…